Mandatory preoperative requirements include: NPO for at least 8 hours, confirmation of coagulation profile, urinalysis and urine culture to rule out active infection, administration of prophylactic intravenous antibiotics, anesthesia assessment, and informed surgical consent.
Post-operative care involves continuous bladder irrigation (CBI) to prevent clot retention, strict monitoring of vital signs and urine output, early mobilization, pain management via analgesics, and monitoring for signs of bladder perforation or sepsis. Discharge occurs once the patient is hemodynamically stable, passing clear or light pink urine, and tolerating oral intake.
Comprehensive Clinical Guide: Transurethral Resection of Bladder Tumor (TURBT)
1. Introduction and Overview
Transurethral Resection of Bladder Tumor (TURBT) remains the gold standard procedure for the initial diagnosis, staging, and therapeutic management of bladder cancer. As a minimally invasive surgical intervention, it involves the endoscopic removal of bladder tumors via the urethra, eliminating the need for an external abdominal incision.
For the urological surgeon, the primary goal of a TURBT is twofold: to obtain high-quality tissue specimens for histopathological grading and staging, and to achieve complete resection of all visible malignant lesions. In many cases of non-muscle-invasive bladder cancer (NMIBC), TURBT serves as the definitive treatment.
2. Technical Specifications and Mechanisms
The procedure utilizes a specialized instrument known as a resectoscope. This device consists of an optical system (cystoscope) and a wire loop electrode powered by high-frequency electrical current (diathermy).
The Mechanism of Action
- Monopolar vs. Bipolar Resection: Traditional monopolar TURBT involves an electrical current traveling from the loop, through the patient, to a grounding pad. Modern practice is increasingly shifting toward Bipolar TURBT, which utilizes saline irrigation and restricts the current path between two electrodes on the tip of the resectoscope, significantly reducing the risk of obturator nerve stimulation and bladder perforation.
- Visualization: High-definition fiber-optic cameras provide the surgeon with a magnified view of the bladder mucosa, allowing for the identification of papillary, sessile, or carcinoma-in-situ (CIS) lesions.
- Fluorescence-Guided Surgery: Techniques such as Blue Light Cystoscopy (BLC) involve the intravesical instillation of hexaminolevulinate, which accumulates in malignant cells and causes them to fluoresce under blue light, enhancing the detection of flat lesions often missed by white light alone.
3. Clinical Indications and Usage
TURBT is indicated whenever there is suspicion of bladder malignancy. This suspicion typically arises from:
* Gross or Microscopic Hematuria: The most common presenting symptom.
* Abnormal Imaging: Findings on CT urograms or ultrasounds suggestive of intravesical masses.
* Positive Urinary Cytology: Indicative of high-grade malignancy or CIS.
Indications Summary Table
| Indication | Clinical Rationale |
|---|---|
| Primary Diagnosis | Histological confirmation of tumor grade and stage. |
| Staging | Determination of T-stage (Ta, T1, T2) to guide further therapy. |
| Therapeutic Removal | Complete excision of visible papillary tumors. |
| Surveillance | Periodic assessment for recurrence in high-risk patients. |
4. Pre-Operative Preparation
A systematic approach to pre-op care is essential to mitigate anesthesia risks and post-surgical complications.
- Laboratory Assessment: CBC, coagulation profile (PT/INR/PTT), and serum creatinine are mandatory.
- Urinalysis & Culture: Any active urinary tract infection (UTI) must be treated with antibiotics prior to surgery to prevent urosepsis.
- Anticoagulation Management: Patients on antiplatelet agents (e.g., Clopidogrel) or anticoagulants (e.g., Warfarin, Apixaban) require careful bridging or temporary cessation based on the risk of bleeding versus thromboembolic events.
- Anesthesia Planning: Can be performed under general anesthesia or regional (spinal) anesthesia. Spinal is often preferred in elderly populations to reduce cardiovascular and pulmonary risks.
5. Procedural Steps: The Intraoperative Phase
The procedure follows a standardized sequence to ensure safety and completeness:
- Step 1: Patient Positioning: The patient is placed in the lithotomy position.
- Step 2: Cystourethroscopy: Systematic inspection of the urethra and the entire bladder wall, including the dome, lateral walls, and trigone.
- Step 3: Resection: The surgeon uses the wire loop to systematically excise the tumor. If the tumor is large, the exophytic portion is resected first, followed by the base.
- Step 4: Muscularis Propria Sampling: It is critical to include the underlying detrusor muscle in the specimen. This is the only way to accurately stage the tumor (distinguishing between T1 and T2).
- Step 5: Hemostasis: After resection, the base of the tumor is fulgurated (cauterized) to ensure complete hemostasis.
- Step 6: Irrigation: Continuous irrigation is used to clear debris and blood clots from the bladder.
6. Post-Operative Recovery Protocol
- Continuous Bladder Irrigation (CBI): Often initiated post-operatively to prevent clot formation and obstruction of the catheter.
- Catheter Management: Usually removed within 24–48 hours depending on the degree of hematuria.
- Early Instillation of Chemotherapy: A single dose of intravesical chemotherapy (e.g., Mitomycin C or Gemcitabine) is often administered within 6 hours post-op for low-risk NMIBC to reduce the risk of tumor cell implantation.
- Activity Restriction: Patients are advised to avoid heavy lifting and strenuous activity for 2–4 weeks to prevent secondary hemorrhage.
7. Potential Complications
While generally safe, TURBT carries specific surgical risks:
- Bladder Perforation: Occurs if the resection extends through the bladder wall. Extra-peritoneal perforation is usually managed with prolonged catheterization; intra-peritoneal perforation may require surgical repair.
- Obturator Nerve Reflex: A violent movement of the leg caused by electrical stimulation of the nerve during lateral wall resection, which can lead to accidental perforation.
- Secondary Hemorrhage: Occurs 7–14 days post-op as the eschar (scab) falls off the resection site.
- Urethral Stricture: A long-term complication caused by trauma during the insertion of the resectoscope.
8. Alternative and Adjunctive Treatments
TURBT is rarely the sole treatment for high-risk bladder cancer. It is often integrated into a multimodal strategy:
* Intravesical Immunotherapy (BCG): Used for high-risk NMIBC to stimulate an immune response against remaining malignant cells.
* Radical Cystectomy: Indicated if the TURBT reveals muscle-invasive disease (T2 or higher).
* Trimodality Therapy: A combination of maximal TURBT, radiation, and concurrent chemotherapy for patients who are not candidates for or refuse radical cystectomy.
9. Massive FAQ Section
1. How long does the TURBT procedure typically take?
Most procedures take between 30 to 90 minutes, depending on the size, number, and location of the tumors.
2. Will I need a catheter after the surgery?
Yes, almost all patients will wake up with a Foley catheter to ensure the bladder remains empty and to monitor for bleeding.
3. What is the difference between Ta and T1 tumors?
Ta tumors are confined to the lining of the bladder (urothelium), whereas T1 tumors have invaded the connective tissue (lamina propria) beneath the lining.
4. Is the procedure painful?
During the procedure, you will be under anesthesia. Post-operatively, you may experience bladder spasms or burning during urination, which are managed with antispasmodics and analgesics.
5. What is the risk of the cancer coming back?
Bladder cancer has a high recurrence rate. Regular follow-up cystoscopies are mandatory for years following the initial TURBT.
6. Can I go home on the same day?
For small, simple tumors, same-day discharge is possible. For larger tumors or those with high risk of bleeding, an overnight stay is standard.
7. What should I do if I see blood in my urine after discharge?
Small amounts of blood are normal for a few days. However, if you see large clots, are unable to urinate, or have a fever, you should contact your urologist immediately.
8. Does TURBT affect sexual function?
TURBT generally does not impact sexual function, as it does not involve the removal of the bladder or surrounding organs related to sexual performance.
9. Why is the "muscle" sample so important?
The pathologist needs to see the muscle layer to confirm the tumor has not invaded deeper. Without muscle in the sample, the tumor cannot be accurately staged.
10. How soon can I return to work?
Most patients can return to light work within 1–2 weeks, but heavy lifting should be avoided for at least 4 weeks.
10. Clinical Conclusion
TURBT is the cornerstone of urologic oncology for bladder cancer. Its success relies on the surgeon’s ability to perform a high-quality, systematic resection while minimizing the risk of perforation. By combining meticulous surgical technique, appropriate imaging adjuncts, and rigorous post-operative follow-up, clinicians can significantly improve patient outcomes and long-term prognosis in bladder cancer management.
Disclaimer: This guide is for educational purposes for healthcare professionals and patients. It does not replace the advice of a board-certified urologist. Always consult with your medical team for personalized clinical decisions.